Literature DB >> 27236785

Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.

Kristian Gaarn du Jardin1, Nico Liebenberg2, Heidi Kaastrup Müller2, Betina Elfving2, Connie Sanchez2,3, Gregers Wegener2,4.   

Abstract

RATIONALE: The mechanisms mediating ketamine's antidepressant effect have only been partly resolved. Recent preclinical reports implicate serotonin (5-hydroxytryptamine; 5-HT) in the antidepressant-like action of ketamine. Vortioxetine is a multimodal-acting antidepressant that is hypothesized to exert its therapeutic activity through 5-HT reuptake inhibition and modulation of several 5-HT receptors.
OBJECTIVES: The objective of this study was to evaluate the therapeutic-like profiles of S-ketamine, vortioxetine, and the serotonin reuptake inhibitor fluoxetine in response to manipulation of 5-HT tone.
METHOD: Flinders Sensitive Line (FSL) rats, a genetic model of depression, were depleted of 5-HT by repeated administration of 4-chloro-DL-phenylalanine methyl ester HCl (pCPA). Using pCPA-pretreated and control FSL rats, we investigated the acute and sustained effects of S-ketamine (15 mg/kg), fluoxetine (10 mg/kg), or vortioxetine (10 mg/kg) on recognition memory and depression-like behavior in the object recognition task (ORT) and forced swim test (FST), respectively.
RESULTS: The behavioral phenotype of FSL rats was unaffected by 5-HT depletion. Vortioxetine, but not fluoxetine or S-ketamine, acutely ameliorated the memory deficits of FSL rats in the ORT irrespective of 5-HT tone. No sustained effects were observed in the ORT. In the FST, all three drugs demonstrated acute antidepressant-like activity but only S-ketamine had sustained effects. Unlike vortioxetine, the antidepressant-like responses of fluoxetine and S-ketamine were abolished by 5-HT depletion.
CONCLUSIONS: These observations suggest that the acute and sustained antidepressant-like effects of S-ketamine depend on endogenous stimulation of 5-HT receptors. In contrast, the acute therapeutic-like effects of vortioxetine on memory and depression-like behavior may be mediated by direct activity at 5-HT receptors.

Entities:  

Keywords:  Antidepressants; Fluoxetine; Forced swim test; Ketamine; Object recognition; Serotonin; Vortioxetine

Mesh:

Substances:

Year:  2016        PMID: 27236785     DOI: 10.1007/s00213-016-4327-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

1.  The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat.

Authors:  K Rutten; C Lieben; L Smits; A Blokland
Journal:  Psychopharmacology (Berl)       Date:  2007-01-30       Impact factor: 4.530

Review 2.  How does ketamine elicit a rapid antidepressant response?

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Curr Opin Pharmacol       Date:  2014-11-25       Impact factor: 5.547

3.  Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Karine F Ribeiro; Ana K Ferraro; Marcelo F Vitto; Patrícia Cesconetto; Claúdio T Souza; João Quevedo
Journal:  Behav Brain Res       Date:  2011-03-21       Impact factor: 3.332

4.  Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats.

Authors:  Lucielli Savegnago; Cristiano R Jesse; Larissa G Pinto; Joao B T Rocha; Cristina W Nogueira; Gilson Zeni
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-05-25       Impact factor: 5.067

5.  Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Authors:  Marije aan het Rot; Katherine A Collins; James W Murrough; Andrew M Perez; David L Reich; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382

6.  Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.

Authors:  Kristian Gaarn du Jardin; Jesper Bornø Jensen; Connie Sanchez; Alan L Pehrson
Journal:  Eur Neuropsychopharmacol       Date:  2013-08-02       Impact factor: 4.600

Review 7.  Monoamine dysfunction and the pathophysiology and treatment of depression.

Authors:  D S Charney
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques.

Authors:  H Yamanaka; C Yokoyama; H Mizuma; S Kurai; S J Finnema; C Halldin; H Doi; H Onoe
Journal:  Transl Psychiatry       Date:  2014-01-07       Impact factor: 6.222

9.  Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.

Authors:  Elena Dale; Hong Zhang; Steven C Leiser; Yixin Xiao; Dunguo Lu; Charles R Yang; Niels Plath; Connie Sanchez
Journal:  J Psychopharmacol       Date:  2014-08-13       Impact factor: 4.153

10.  Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.

Authors:  Agnieszka Nikiforuk; Tomasz Kos; Katarzyna Fijał; Małgorzata Hołuj; Dominik Rafa; Piotr Popik
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more
  23 in total

Review 1.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

2.  S-Ketamine Reverses Hippocampal Dendritic Spine Deficits in Flinders Sensitive Line Rats Within 1 h of Administration.

Authors:  Giulia Treccani; Maryam Ardalan; Fenghua Chen; Laura Musazzi; Maurizio Popoli; Gregers Wegener; Jens Randel Nyengaard; Heidi Kaastrup Müller
Journal:  Mol Neurobiol       Date:  2019-04-29       Impact factor: 5.590

Review 3.  Rodent ketamine depression-related research: Finding patterns in a literature of variability.

Authors:  Andrew J Polis; Paul J Fitzgerald; Pho J Hale; Brendon O Watson
Journal:  Behav Brain Res       Date:  2019-08-13       Impact factor: 3.332

4.  Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation.

Authors:  Kenichi Fukumoto; Manoela V Fogaça; Rong-Jian Liu; Catharine H Duman; Xiao-Yuan Li; Shigeyuki Chaki; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2020-05-12       Impact factor: 7.853

5.  Rapid effects of S-ketamine on the morphology of hippocampal astrocytes and BDNF serum levels in a sex-dependent manner.

Authors:  Maryam Ardalan; Betina Elfving; Ali H Rafati; Monireh Mansouri; Carlos A Zarate; Aleksander A Mathe; Gregers Wegener
Journal:  Eur Neuropsychopharmacol       Date:  2020-01-20       Impact factor: 4.600

6.  Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat.

Authors:  Inge Oberholzer; Marisa Möller; Brendan Holland; Olivia M Dean; Michael Berk; Brian H Harvey
Journal:  Metab Brain Dis       Date:  2017-11-03       Impact factor: 3.584

Review 7.  Vortioxetine for depression in adults.

Authors:  Markus Koesters; Giovanni Ostuzzi; Giuseppe Guaiana; Johanna Breilmann; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2017-07-05

Review 8.  The role of serotonin neurotransmission in rapid antidepressant actions.

Authors:  A L Pehrson; D Roberts; A Khawaja; R McNair
Journal:  Psychopharmacology (Berl)       Date:  2022-03-25       Impact factor: 4.530

9.  Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?

Authors:  Shigeyuki Chaki
Journal:  Int J Neuropsychopharmacol       Date:  2018-02-01       Impact factor: 5.176

10.  Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.

Authors:  Marie Spies; Gregory M James; Neydher Berroterán-Infante; Harald Ibeschitz; Georg S Kranz; Jakob Unterholzner; Mathis Godbersen; Gregor Gryglewski; Marius Hienert; Johannes Jungwirth; Verena Pichler; Birgit Reiter; Leo Silberbauer; Dietmar Winkler; Markus Mitterhauser; Thomas Stimpfl; Marcus Hacker; Siegfried Kasper; Rupert Lanzenberger
Journal:  Int J Neuropsychopharmacol       Date:  2018-02-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.